Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-04

FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved a supplemental application for NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) by Haleon US Holdings LLC. The approval concerns the new product for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEXIUM 24HR CLEARMINIS (Esomeprazole magnesium)

Snippet

SUPPL AP for NEXIUM 24HR CLEARMINIS (ESOMEPRAZOLE MAGNESIUM)